Lowest Price Guaranteed
Slides
243
Last Updated
April 2025
View Count
11517
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Introduction
2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative
2.4.2.3. Advantages
2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions
2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Hospitals
2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach
3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)
3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis
3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation
3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Theranostics
6.2.1. Key Characteristics of Theranostics
6.2.2. Key Applications of the Theranostics
6.2.3. Challenges Associated with Theranostics
6.3. Future Perspective
7. COMPETITIVE LANDSCAPE
7.1. Chapter Overview
7.2. Theranostics Companies: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters
7.2.4. Theranostics: Overall Market Landscape
7.2.4.1. Analysis by Product
7.2.4.2. Analysis by Application Area Type
7.2.4.3. Analysis by End Users
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodologies
8.4. Company Competitiveness Analysis: Theranostics Companies
8.4.1. Theranostics Companies Based in North America (Peer Group 1)
8.4.2. Theranostics Companies Based in Europe (Peer Group 2)
8.4.3. Theranostics Companies Based in Asia-Pacific (Peer Group 3)
8.4.4. Theranostics Companies Based in Middle East and North Africa, and Latin America (Peer Group 4)
8.5. Key Findings
9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Agilent Technologies
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Service / Product Portfolio
9.2.4. Recent Developments and Future Outlook
* Similar details are presented for other below mentioned companies based on information in the public domain
9.3. AmeriPath
9.4. Abbott Laboratories
9.5. Beckman Coulter
9.6. Foundation Medicine
9.7. Focus Diagnostics
9.8. GE Healthcare
9.9. Illumina
9.10. Leica Biosystems
9.11. Myriad Genetics
9.12. Nussloch
9.13. Pfizer
9.14. Qiagen
9.15. Roche
9.16. Thermo Fisher Scientific
10. SWOT ANALYSIS
11. MARKET IMPACT ANALYSIS
11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion
12. GLOBAL THERANOSTICS MARKET
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Trends Disruption Impacting Market
12.4. Global Theranostics Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
12.5. Multivariate Scenario Analysis
12.5.1. Conservative Scenario
12.5.2. Optimistic Scenario
12.6. Key Market Segmentations
13. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Revenue Shift Analysis
13.4. Market Movement Analysis
13.5. Penetration-Growth (P-G) Matrix
13.6. Theranostics Market for Diagnostic Imaging: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.6.1. Theranostics Market for MRI: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.6.2. Theranostics Market for PET Imaging: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.6.3. Theranostics Market for Nuclear Imaging: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.6.4. Theranostics Market for CT Scan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.6.5. Theranostics Market for Molecular Imaging: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.6.6. Theranostics Market for Other Diagnostic Imaging: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7. Theranostics Market for Radiopharmaceuticals: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.1. Theranostics Market for Lutetium-177: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.2. Theranostics Market for Samarium-153: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.3. Theranostics Market for Radium-223: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.4. Theranostics Market for Iodine-131: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.5. Theranostics Market for Yttrium-90: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.6. Theranostics Market for Gallium-68: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.7. Theranostics Market for Fluorine-18: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7.8. Theranostics Market for Other Radiopharmaceuticals: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.8. Theranostics Market for IVD / Biomarker Screening: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.8.1. Theranostics Market for Polymerase Chain Reaction: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.8.2. Theranostics Market for Next-Generation Sequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.8.3. Theranostics Market for Fluorescence In-Situ Hybridization: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.9. Theranostics Market for Software and Services: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.10. Data Triangulation and Validation
14. MARKET OPPORTUNITIES BASED ON APPLICATION AREA
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Revenue Shift Analysis
14.4. Market Movement Analysis
14.5. Penetration-Growth (P-G) Matrix
14.6. Theranostics Market for Prostate Cancer: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.7. Theranostics Market for Bone Metastasis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.8. Theranostics Market for Neuroendocrine Tumors: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.9. Theranostics Market for Lymphoma: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.10. Theranostics Market for Cardiovascular Diseases: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.11. Theranostics Market for Other Applications: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.12. Data Triangulation and Validation
15. MARKET OPPORTUNITIES BASED ON TYPE OF END USER
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Revenue Shift Analysis
15.4. Market Movement Analysis
15.5. Penetration-Growth (P-G) Matrix
15.6. Theranostics Market for Hospitals: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.7. Theranostics Market for Diagnostics Centers: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.8. Theranostics Market for Specialty Clinics: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.9. Theranostics Market for Other End Users: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.10. Data Triangulation and Validation
16. MARKET OPPORTUNITIES FOR THERANOSTICS IN NORTH AMERICA
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix
16.6. Theranostics Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.6.1. Theranostics Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.6.2. Theranostics Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.6.3. Theranostics Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.7. Data Triangulation and Validation
17. MARKET OPPORTUNITIES FOR THERANOSTICS IN EUROPE
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. Theranostics Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.6.1. Theranostics Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.6.2. Theranostics Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.6.3. Theranostics Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.6.4. Theranostics Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.6.5. Theranostics Market in the UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.6.6. Theranostics Market in Rest of Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.7. Data Triangulation and Validation
18. MARKET OPPORTUNITIES FOR THERANOSTICS IN ASIA-PACIFIC
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. Theranostics Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.1. Theranostics Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.2. Theranostics Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.3. Theranostics Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.4. Theranostics Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.5. Theranostics Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.7. Data Triangulation and Validation
19. MARKET OPPORTUNITIES FOR THERANOSTICS IN MIDDLE EAST AND NORTH AFRICA (MENA)
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix
19.6. Theranostics Market in Middle East and North Africa (MENA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.1. Theranostics Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 205)
19.6.2. Theranostics Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.3. Theranostics Market in United Arab Emirates (UAE): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.7. Data Triangulation and Validation
20. MARKET OPPORTUNITIES FOR THERANOSTICS IN LATIN AMERICA
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix
20.6. Theranostics Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.1. Theranostics Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.2. Theranostics Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.7. Data Triangulation and Validation
21. APPENDIX 1: TABULATED DATA
22. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
23. CUSTOMIZATION OPPORTUNITIES
24. ROOTS SUBSCRIPTION SERVICES
25. AUTHOR DETAIL